Photo: Albert Stoynov / Unsplash
ProPublica reports that a spa company's disease-screening arm won federal Ebola awards months after a fund tied to the president's sons invested in its parent.
Background
XpresTest is the disease-screening subsidiary of XWELL, a New York company founded in 2006 as a chain of airport spas and known during the pandemic as XpresSpa Group [1]. During COVID-19 it received $5.5 million from the CDC to test travelers, and it collected waste from airplane toilets to look for new viral strains [1]. According to ProPublica, it had never worked with Ebola or provided biosecurity services abroad, and last year most of its revenue still came from waxing salons and airport spas offering manicures and massages [1]. Few résumés go from manicures to pathogen surveillance quite this quickly.
In February, American Ventures, a fund launched by Dominari Holdings, a small financial firm with offices in Trump Tower, invested about $30 million in XWELL [1]. ProPublica reports XWELL had been valued at roughly $3 million beforehand; the fund received an initial stake of about 10% plus an option to issue millions more shares [1]. Dominari's leaders had hired Donald Trump Jr. and Eric Trump as advisers after their father won a second term and gave them a stake of more than 10% in Dominari itself [1].
What the Records Show
Two federal awards followed. Federal spending records list an $18.8 million CDC contract to XpresTest, signed July 6, 2026, for "Ebola entry screening services," with a performance period ending in July 2027 [2]. ProPublica reports the work covers screening at several U.S. airports [1]. The record puts the contract's potential value, including options, at about $35.5 million and classifies it as a sole-source award under an urgency exception [2].
The second is a $20 million State Department cooperative agreement, signed September 25, 2026, for rapid outbreak response in the Democratic Republic of the Congo, running through September 2028 [3]. ProPublica reports that the Congo outbreak has killed more than 5,000 people this year, and that the two awards together are seven times the total value of government contracts the company had directly received before [1].
After the CDC award, XWELL announced in July a plan to sell XpresTest and its spa line to a private facial spa company for $13 million [1]. Chief executive Ezra Ernst told ProPublica the contracts played a role in that price and would move with XpresTest to its new owner [1]. XWELL did not publicly announce either award [1].
The Questions and the Responses
ProPublica does not allege that anyone broke the law. The questions it raises concern experience and access. Jeremy Konyndyk, who helped oversee the U.S. response to the 2014 Ebola outbreak in West Africa, told ProPublica it was concerning that the government would pick a firm with no experience in Africa [1]. Ernst himself was candid: "This is a risky contract. I'm not sure we can do it" [1]. He described international work as new for the company and said XpresTest won both awards through competitive bidding [1]. The CDC record, however, lists its contract as sole-source [2]. In my view, that label deserves as much scrutiny as the shareholder list.
The State Department told ProPublica its award was made through a competitive process that built on the firm's CDC airport work [1]. The CDC did not respond to ProPublica's request for comment [1].
A spokesperson for Donald Trump Jr. and Eric Trump said the brothers are passive minority investors in a fund that invested in the company and had no involvement in or knowledge of the negotiation or procurement of its contracts [1]. Dominari chief executive Anthony Hayes said he had never seen or heard of the brothers using their family name to influence a government contract [1]. ProPublica does not report that either brother had a role in the awards.
What Comes Next
Democrats won control of both chambers of Congress in last week's midterms, and ProPublica reports that the Trump family's financial ties to government deals are expected to be a major focus of congressional oversight in the coming months [1]. Rep. Robert Garcia, the top Democrat on the House Oversight Committee, has written to colleagues warning that using government for personal gain erodes public trust and wastes taxpayer money [1]. The same fund also backed Powerus, a Florida drone company that later won an Air Force contract worth up to $90 million [1].
For now, the CDC contract runs into mid-2027 and the Congo award into 2028 [2][3]. Whether XpresTest can deliver, and how it was chosen, are questions the new Congress appears ready to ask.
This article is for informational purposes only and is not medical advice; readers with health questions should consult their clinician.
References
Lerner S, Barry-Jester AM, Faturechi R. Firm Linked to Trump's Sons Got Nearly $40 Million in Federal Contracts to Screen for Ebola and Other Diseases. ProPublica. November 9, 2026. https://www.propublica.org/article/trump-sons-xwell-xprestest-government-contracts
USAspending.gov. Contract 75D30126C21193: Centers for Disease Control and Prevention to XpresTest Inc., Ebola entry screening services. Accessed November 11, 2026. https://www.usaspending.gov/award/CONT_AWD_75D30126C21193_7523_-NONE-_-NONE-
USAspending.gov. Cooperative agreement SAQMMA26CA0383: U.S. Department of State to XpresTest Inc., outbreak response in the Democratic Republic of the Congo. Accessed November 11, 2026. https://www.usaspending.gov/award/ASST_NON_SAQMMA26CA0383_019